Clinical Utility Study for Exo-PDAC

This is a national-level research study of oncologists, interventional gastroenterologists, and primary care providers. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling and other) of a subset of common patient care indications.

Inclusion Criteria:Board-certified for at least two yearsAveraging at least 20 hours per week of clinical and patient care duties over the last six monthsRoutinely evaluate patients at risk for pancreatic cancer in their practicePracticing in the U.S.English speakingAccess to the internetInformed, signed, and voluntarily consented to be in the studyExclusion Criteria:Non-English speakingUnable to access the internetNot practicing in the U.S.Not averaging at least 20 hours per week of clinical or patient care duties over the last six monthsPrevious exposure to the testDo not voluntarily consent to be in the study